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Abstract
Gut-homing of donor T cells is causative for the development of intestinal GvHD in recipients of allogeneic hematopoietic
stem cell transplantation (HSCT). Expression of the gut-specific homing receptors integrin-a4b7 and chemokine receptor
CCR9 on T cells is imprinted in gut-associated lymphoid tissues (GALT) under the influence of the vitamin A metabolite
retinoic acid. Here we addressed the role of vitamin A deficiency in HSCT-recipients for donor T cell migration in the course
of experimental GvHD. Vitamin A-deficient (VAD) mice were prepared by feeding them a vitamin A-depleted diet.
Experiments were performed in a C57BL/6 into BALB/c model of acute GvHD. We found that expression of integrin-a4b7
and CCR9 in GALT was reduced in VAD recipients after HSCT. Competitive in vivo homing assays showed that allogeneic
T cells primed in VAD mice did not home as efficiently to the intestine as T cells primed in mice fed with standard diet (STD).
The course of GvHD was ameliorated in VAD HSCT-recipients and, consequently, their survival was prolonged compared to
recipients receiving STD. However, VAD-recipients were not protected and died of clinical GvHD. We found reduced
numbers of donor T cells in the intestine but increased cell counts and tissue damage in other organs of VAD-recipients.
Furthermore, we observed high IFN-c
+CD4
+ and low FoxP3
+CD4
+ frequencies of total donor CD4
+ T cells in VAD as
compared to STD recipients. Taken together, these results indicate that dietary vitamin A deficiency in HSCT-recipients
changed target organ tropism in GvHD but also resulted in fatal inflammation after HSCT.
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Introduction
Graft-versus-host-disease (GvHD) is a frequent complication
after allogeneic hematopoietic stem cell transplantation (HSCT).
Acute GvHD results from an aggressive immune response of
alloreactive donor T cells directed against host tissue and affects
mostly liver, lung, skin and intestine [1]. Intestinal GvHD can
involve any location throughout the gastrointestinal tract and is
associated with high morbidity and mortality. Therefore, inhibi-
tion or reduction of intestinal GvHD is likely to significantly
improve patient’s health and survival. Key events in the
development of intestinal GvHD are the generation of alloreactive
T cells with gut homing potential and the recruitment of allogeneic
effector T cells to the intestinal tract [1]. Shortly after allogeneic
HSCT, naı ¨ve donor T cells enter secondary lymphoid organs
(SLO). After heavy alloantigen-induced proliferation, primed and
activated donor T cells leave SLO and enter the host’s organs
where they induce severe tissue injury [2]. Thus, inhibition of
either the generation of gut-homing T cells or preventing their
access to the intestine should counteract the development of
intestinal GvHD [3].
Under homeostatic, i.e. non-inflammatory conditions T cell
homing into the intestine is regulated by selective interactions of
intestinal homing molecules expressed on the surface of T cells and
their corresponding ligands expressed in the intestinal mucosa.
The integrin-a4b7 is the main adhesion molecule required for
lymphocyte entry into the gut-associated lymphoid tissues (GALT),
such as mesenteric lymph nodes (mLN) and Peyer’s Patches (PP)
and also into the intestinal lamina propria [4]. Furthermore,
expression of CC chemokine receptor 9 (CCR9) on T cells directs
these cells to the small intestine [5]. Integrin-a4b7 interacts
specifically with its ligand mucosal addressin cell adhesion
molecule-1 (MAdCAM-1) on intestinal microvascular endotheli-
um, whereas the CC chemokine ligand 25 (CCL25), which is a
ligand for CCR9, is selectively expressed in the mucosa of the
small intestine but not the colon [6]. Expression of a4b7-integrin
and CCR9 are selectively induced during naı ¨ve T cell activation in
mLN and GALT [7]. In this process, the vitamin A metabolite
retinoic acid (RA) has been identified as the central mediator
regulating the expression of integrin-a4b7 and CCR9 on T cells in
mLN and GALT [8]. The predominant sources of RA seem to be
local dendritic cells (DCs) [8], epithelial [9] and stroma cells [10].
In contrast to physiological steady state conditions, T cell homing
to the inflamed intestine is not entirely understood. The relevance
of integrin-a4b7 expression on donor T cells for intestinal GvHD
has been demonstrated [11,12], whereas the role of CCR9
expression during acute GvHD is unclear.
Based on all these observations we hypothesized that gut-
homing of donor T cells during GvHD is likely to be dependent on
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expression of integrin-a4b7 and CCR9 on allogeneic T cells.
Accordingly, a lack of RA should reduce the ability of donor
T cells to migrate to the intestine and thus protect from intestinal
GvHD. In this study, we thus addressed the role of vitamin A
deficiency in HSCT recipients in the course of experimental
GvHD. We examined the contribution of dietary vitamin A to the
induction of gut-homing molecules on allogeneic T cells in
lymphoid organs and their subsequent role during T cell entry to
target tissues of acute GVHD. We found that the induction of gut-
homing potential of allogeneic donor T cells relied on vitamin A
and that vitamin A deficiency in recipient mice prolonged survival
from acute GvHD. However, dietary lack of vitamin A did not
prevent GvHD and all mice ultimately died of clinically evident
disease. We observed increased frequencies of IFN-c-producing
CD4
+ T cells and reduced FoxP3
+ regulatory T cells (Treg) in
GvHD target organs of VAD recipients. This finding was
particularly associated with strong T cell influx and tissue damage
of the liver under vitamin A-deficient conditions.
Results
Donor T Cell Expression of CCR9 and Integrin-a4b7
During GvHD Priming Phase is Dependent on Dietary
Vitamin A
Allogeneic T cells enter intestinal target sites following their
activation and proliferation in GALT [2]. In order to identify the
homing molecules that enabled donor T cells to migrate to the
inflamed intestine during acute GvHD, we adoptively transferred
allogeneic donor T cells into irradiated recipient mice and
examined expression of adhesion molecules during allogeneic
T cell priming in vivo. Thy1.1
+ C57BL/6 donor T cells were
labeled with CFSE and transferred into irradiated recipient
BALB/c mice. Three days later, allogeneic donor T cells had
undergone more than five divisions in the recipients’ SLOs, which
is in line with published data [13]. In mLN, CCR9 and a4b7-
integrin were induced at high levels on both donor CD4
+ and
CD8
+ T cells (Figure 1A, C). The pattern of rapid acquisition of
CCR9 and b7 on CD4
+ and CD8
+ donor T cells after several
rounds of cell proliferation was similar to previous observations in
experimental GvHD [13]. As expected, the majority of CCR9
+
and a4b7-integrin
+ donor CD4
+ and CD8
+ T cells were CD62L
negative (Figure 1B).
Next, we raised BALB/c mice from gestational day 14 onward
with a diet that lacked vitamin A and then used these VAD
animals as recipients for bone marrow transplantation to
determine the influence of dietary vitamin A on expression of
gut-homing molecules such as CCR9 and integrin-a4b7o n
allogeneic T cells after bone marrow transplantation.
Three days after transplantation, we observed significantly
lower induction of CCR9 and integrin-a4b7 on CD4
+ donor
T cells in GALT of VAD recipient mice when compared to mice
fed with STD (Figure 1A). The same effect was observed on
CD8
+ donor T cells for CCR9 and integrin-a4b7( Figure 1A).
This observation was not seen in peripheral lymph nodes (pLN)
where expression of these molecules was low and independent of
the type of diet fed (Figure 1C). Of note, the proliferation of
donor T cells in mLN was not affected in VAD recipient mice as
determined by CFSE dilution (Figure 1D).
Homing of Allo-primed T Cells to the Intestine is
Dependent on Dietary Vitamin A
Next we sought to determine the impact of VAD on homing
potential of allogeneic donor T cells following their activation.
Therefore we adoptively transferred C57BL/6 T cells (Thy1.1
+)
into lethally irradiated allogeneic STD or VAD mice (BALB/c).
Three days after transfer, VAD and STD recipient mice were
sacrificed and lymphocytes were harvested from mLNs and were
labeled with either CFSE or TAMRA. Mixtures of donor
lymphocytes were adjusted to contain equal T cell numbers and
were then intravenously transferred to untreated syngeneic
(C57BL/6) recipient mice. Sixteen hours later we analyzed the
distribution of T cells in pLN, mLN, spleen, liver, intraepithelial
(IEL) and lamina propria lymphocytes (LPL) in the small intestine.
Recovered allo-primed donor lymphocytes were identified in
FACS by the congenic marker Thy1.1. The analyses revealed that
intestinal homing of donor CD4
+ (Figure 2A) and CD8
+ T cells
(Figure 2B) primed in VAD mice was reduced as compared to
cells primed in STD recipients. Of note, there was no difference in
homing of VAD or STD primed T cells to the non-inflamed liver
in these experiments.
These competitive transfer experiments demonstrated that
VAD during the priming process in the host organism was
sufficient to impair homing of allo-primed T cells to the non-
inflamed intestine.
Vitamin A Deficiency in HSCT Recipients Ameliorates
Acute GvHD
The intestine is the largest GvHD target organ and protection
from intestinal GvHD through impaired donor T cell gut-homing
has been shown to prolong survival in several models of
experimental GvHD [11,12]. Since donor T cells primed in
VAD recipients were not able to home efficiently to the intestine,
we investigated whether VAD recipients would be protected from
development of intestinal GvHD and consequently also from lethal
outcome of the disease. Therefore, lethally irradiated (800cGy)
VAD or STD recipient mice (BALB/c) were transplanted with
5610
6 T cell depleted bone marrow (TCD-BM) from allogeneic
(C57BL/6) donors along with 1610
6 splenic T cells from either
C57BL/6 or syngeneic BALB/c donors. VAD animals were
further kept under vitamin A deficient food after transplantation,
whereas STD mice received standard diet throughout the duration
of the experiment (60 days). Under otherwise identical conditions,
VAD and STD animals transplanted with syngeneic grafts
survived without any signs of acute GvHD for the time of follow
up (Figure 3). In the groups receiving allogeneic T cells, the
survival of VAD recipients was significantly prolonged when
compared to STD recipients. However, all VAD mice that
received allogeneic T cells, developed clinical signs of GvHD and
died within 60 days after transplantation. These results suggest
that altered tissue tropism of T cells prolonged survival in GvHD
but since all animals died, other factors must have influenced the
course of the disease.
Donor T Cells are Reduced in Numbers in the Intestine of
VAD Recipients but Accumulate in the Liver during Acute
GvHD
To test whether homing of donor T cells is altered under VAD
conditions during GvHD, we assessed the infiltration of donor
CD4
+ and CD8
+ T cell into GvHD-target organs. To that end,
liver, small bowel, mLN, and spleen of the recipients were
harvested at different time points after transplantation and the
percentage of infiltrating CD4
+ and CD8a
+ donor T cells
(Thy1.1
+) was determined by FACS analysis. Interestingly, when
analyzing homing of donor T cells to GvHD target tissues under
highly inflammatory conditions early after transplantation we
failed to detect differences in VAD as compared to STD
Vitamin A and Acute GvHD
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significantly reduced frequencies of donor CD4
+ and CD8
+ T cells
in the intestines of VAD as compared to STD recipients three
weeks after transplantation (Figure 4A, B). At that time we also
observed significantly higher frequencies of CD8
+ and CD4
+
donor T cells in the livers of VAD recipients. There was no
difference in CD4
+ or CD8
+ T cell frequencies in mLN or spleen
detected in both groups (Figure 4A, B). When analyzing absolute
numbers of donor CD4
+ and CD8
+ T cell in GvHD target organs
we observed less accumulation of CD4
+, but not of CD8
+ T cells in
small intestines of VAD-recipients. Although there was a clear
trend, CD4
+ T cell numbers were not significantly increased in
livers of VAD recipients, whereas we observed significantly higher
CD8
+ T cell counts in this organ (Figure 4C, D). These results
indicate that lack of dietary vitamin A alters migration routes of
donor T-cells in experimental GvHD, but also suggest that
mechanisms other than altered homing to the intestine contribute
to a serious damage of other target organs of GvHD such as the
liver.
VAD Alters Donor T Cell Polarization into Th1 and Treg
Cells
It has been reported that VAD can alter CD4
+ T cell
polarization [14,15]. Therefore we speculated that this also
influences the observed phenotype in GvHD in VAD recipients.
To test this, we employed intracellular cytokine (IFN-c, IL-4 and
IL-17) and FoxP3-stainings to analyze CD4
+ T cell lineages after
allogeneic transplantation in target organs of GvHD by flow
cytometry. We found significantly reduced frequencies of
CD4
+FoxP3
+ Treg cells in small intestines of VAD as compared
to STD recipient mice (Figure 5A). In line with findings in other
animal models [14,15], we observed significantly higher frequen-
cies of IFN-c-producing CD4
+ T cells in small intestines, spleen
and livers of VAD as compared to STD recipients (Figure 5B).
We did not observe marked differences in Th2 and Th17 cells
when comparing both groups. Taken together these results suggest
that VAD conditions lead to reduced numbers of Treg cells and
more Th1 cells in target organs of GvHD. Thus, our observations
suggested an enhanced pro-inflammatory scenario due to the
absence of vitamin A in this model.
Vitamin A Deficiency Leads to Increased Hepatic
Inflammation
To estimate systemic inflammation in the course of the disease
we analyzed inflammatory cytokines in the serum of VAD and
STD recipients every week after transplantation. Serum levels of
the pro-inflammatory cytokines interferon-c (IFN-c, IL-6, chemo-
kine C-C motif ligand 2 (CCL2) and tumor necrosis factor a
(TNF-a) were used as global markers for inflammation. Whereas
serum levels of the pro-inflammatory cytokines did not markedly
differ between STD and VAD animals during the first two weeks
after allogeneic HSCT, we observed a significant increase of
CCL2 serum concentrations in VAD recipients as compared to
STD recipients in the third week (Figure 6A). To localize the
source of elevated cytokines and chemokines measured in the
serum we analyzed expression of these proteins in liver and
intestine in both groups after transplantation. In the liver of VAD
recipients we observed higher expression of IFN-c, CCL2 and
TNF levels, whereas we found up-regulation of IL-6 in STD-
recipients. We also found stronger IFN-c-expression in the
intestines of VAD-recipients as compared to STD-mice
(Figure 6B). Three weeks after transplantation, when we also
observed high levels of CCL2, we found enlarged spleens in VAD
recipients as depicted in Figure 6C.
Due to the observed accumulation of donor T cells in the liver
of VAD mice during GvHD, we measured the liver enzymes
alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) in the serum as an indicator for liver injury. VAD recipients
showed increased serum concentrations of AST at day 14 and an
increased concentration of both transaminases, AST and ALT, at
day 21 after transplantation as compared to STD recipients
(Figure 6D). Increased serum concentrations of liver enzymes
such as AST and ALT are indicative of liver cell damage during
GvHD [16]. In line with elevated serum levels of liver enzymes, we
observed extensive signs of tissue damage and cell infiltration in
livers of VAD recipients as compared to STD recipients
(Figure 6E), at the same time tissue damage was low in small
intestines of VAD recipients (Figure 6F). Taken together these
data suggest that Vitamin A deficiency led to a global inflamma-
tion in recipient mice with severe liver damage. We assume that
liver damage together with other secondary effects of VAD finally
led to fatal GvHD.
Discussion
The intestine is the major target organ of acute GvHD, which
frequently accounts for life threatening complications. Assault of
the intestine by alloreactive T cells requires their access to the
tissue. Thus, diversion of T cell migration away from the intestine
is likely to ameliorate the clinical outcome in acute GvHD.
Iwata and colleagues identified the Vitamin A metabolite RA as
the main inducer for gut-homing receptors on T cells [8]. Further
studies showed that not only DCs but also stroma cells are
providers for RA in GALT [10]. Interestingly, mice raised under
Vitamin A deficient conditions contained fewer a4b7
+ T cells than
mice fed with standard diet and these cells failed to efficiently
home to the intestine under steady state conditions [8]. Therefore,
we explored deprivation of Vitamin A and subsequent inhibition
of gut-homing in acute GvHD.
We showed that acquisition of integrin-a4b7 and CCR9 on
allogeneic T cells during GvHD priming phase was dependent on
Vitamin A in the recipients’ diet. In the course of acute GvHD, we
saw diminished accumulation of CD4
+ and CD8
+ donor T cells in
the intestine of VAD recipients when compared to STD recipients.
Figure 1. Donor T cell primed in mesenteric lymph nodes express high levels of gut-homing molecules in recipients under standard
(STD) but not under vitamin A deficient (VAD) food. (A) The expression of CCR9 and integrin-b7 of allogeneic C57BL/6 Thy1.1
+ CFSE-labeled
CD4
+ and CD8
+ T cells was determined by flow cytometry three days following adoptive transfer of 2610
7 splenocytes into lethally irradiated
recipients (BALB/c) fed with STD or VAD diet (N=3/group). The numbers in the boxes indicate the mean percentage of gated cells +/2SD. Similar
results were obtained in at least three repeat experiments. (B) Analysis of donor T cells three days after transfer showed an activated phenotype
(CD62L
2) of CCR9
+ or b7
+ T cells. Representative data from one of two experiments are shown. (C) Expression of CCR9 and integrin-b7 of allogeneic
C57BL/6 Thy1.1
+ CD4
+ and CD8
+ T cells in mLN and pLN (grey=isotype control, red=STD recipient, blue=VAD recipient). Similar results were
obtained in at least three repeat experiments. (D) The proliferation of CFSE-labelled CD4
+ and CD8
+ T cells was determined by flow cytometry three
days following adoptive transfer of 2610
7 splenocytes into lethally irradiated STD or VAD recipients. N=6/group. Combined data from two
experiments (n.s.=not significant).
doi:10.1371/journal.pone.0038252.g001
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prolonged survival in experimental GvHD.
Of interest, the major physiologic metabolite of vitamin A, all-
trans-RA (ATRA), is given to patients for treatment of acute
myeloid leukemia (AML) [17] and has been shown to exert
significant effects on the expression of integrin-a4b7 in vitro [8]. Of
note, AML is currently the most frequent indication for allogeneic
HSCT [18]. Once ATRA-treated patients are referred to
allogeneic HSCT, they have high levels of vitamin A. Therefore,
it is conceivable that high levels of vitamin A could lead to an
increased gut-homing phenotype of T cells and thus ATRA-
treatment might have an influence on the development of
intestinal GvHD after HSCT. Mechanistically, vitamin A may
control expression of retinal dehydrogenase enzymes in mucosal
dendritic cells and gut-draining lymph node stromal cells as
recently shown by Hammerschmidt [19] and Molenaar [20].
However, despite reduced intestinal T cell homing, recipient
mice fed with vitamin A deficient diet were not protected from
lethal GvHD. In this context, it is also important to note that the
induction and expansion of regulatory T cells under homeostatic
conditions and during intestinal inflammation is dependent on
vitamin A [21–23]. Treg cells are of major importance for
reduction of GvHD severity [24]. Therefore we analyzed the
frequencies and absolute numbers of Treg cells in the course of
GvHD. As expected, we observed lower frequencies of FoxP3
+
Treg cells after transplantation in the intestines of VAD as
compared to STD recipients. These results suggested that vitamin
A is necessary for migration, induction and/or expansion of Treg
cells in the gut also during acute GvHD. This result is in line with
recent findings showing that homing, induction and stability of
FoxP3
+CD4
+ T cells depends on vitamin A [23,25]. However, our
survival data indicated that a potential beneficial effect of Treg
numbers can be overcome by adverse mechanisms such as altered
tissue tropism of effector T cells. Furthermore, Treg-mediated
effects influenced by RA are probably more important in chronic
diseases as previously reported by others [25]. This is in line with
previous work from our group showing that induced Treg cells do
not protect from acute GvHD in this model [26]. However, we
observed higher frequencies of Th1 T cells when analyzing the
lineage differentiation of donor CD4
+ T lymphocytes in target
Figure 2. Homing of allo-primed T cells to the intestine is
dependent on dietary vitamin A. 2610
7 splenocytes (C57BL/6)
were transferred into lethally irradiated STD or VAD BALB/c recipients.
Three days after transfer donor T cells from mesenteric lymph nodes of
STD or VAD BALB/c mice were harvested and then split and
differentially labeled with either TAMRA or CFSE. CFSE-labeled cells
from STD recipients were mixed with TAMRA-labeled cells from VAD-
recipients at a 1:1 ratio. In cross-labeling experiments, TAMRA-labeled
cells from STD-recipients and CFSE-labeled cells from VAD-recipients
were used. Mixtures of 5610
6 T cells per mouse in total were injected
into the tail vein of untreated wt C57BL/6 recipient mice. Eighteen
hours after transfer recipient mice were sacrificed and the homing of
CD4
+ and CD8
+ T cells was analyzed by flow cytometry. The ratio of
transferred T cells primed in allogeneic VAD versus STD recipients was
analyzed in pLN (pooled per mouse), SPL, mLN, liver, IEL and LPL.
Labeling effects were excluded by normalizing the ratio to 1:1 in each
staining group. N=6/group. Data are combined from two independent
experiments.
doi:10.1371/journal.pone.0038252.g002
Figure 3. Vitamin A deficiency in HSCT recipients prolongs
survival but does not protect from lethal GvHD. After lethal
irradiation, STD BALB/c or VAD BALB/c recipients received 5610
6
C57BL/6 T cell depleted bone marrow cells supplemented with 1610
6 T
cells (N=14/group). STD BALB/c or VAD BALB/c recipients that received
syngeneic (BALB/c) grafts were used as controls (N=4/group). Data are
combined from two independent experiments.
doi:10.1371/journal.pone.0038252.g003
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(Figure 5). This was also consistent with increased IFN-c
expression as measured by RT-PCR in liver and intestine tissue
samples after GvHD (Figure 6B). It has been shown in different
animal models that vitamin A deficiency promotes Th1 polariza-
tion [14,15]. We confirmed these observations in the present
study. Since the B6BALB/c acute GvHD model is a Th1 type
inflammatory disease [27] the higher frequency of IFN-c
producing CD4
+ T cells might have also contributed to the final
outcome of the disease.
Furthermore, liver enzymes, cytokine expression pattern and
histology revealed severe hepatic GvHD in VAD animals. In line
with this we observed strong accumulation of donor T cells in the
livers of VAD animals after transplantation. Interestingly, we also
Figure 4. Reduced accumulation of donor T cells in the intestine and increased accumulation of donor T cells in the liver of VAD
recipients during acute GvHD. Mice were analyzed for donor T cell (Thy1.1) occurrence in SPL, mLN, liver and small intestine (SI) at day 21 after
transplantation. (A) Each dot represents the percentage of infiltrating Thy1.1
+CD4
+ T cells of all Thy1.1
+CD4
+ T cells. (B) Each dot represent the
percentage of infiltrating Thy1.1
+CD8
+ T cells of all Thy1.1
+CD8
+ T cells. Bars indicate mean values. N=4–5/group. **: p,0.01; ***: p,0.001. Data are
combined from two independent experiments. (C) Each bar represents absolute numbers of infiltrating Thy1.1
+CD4
+ T cells from STD or VAD
recipients. Bars indicate mean values. N=4–5/group. **: p,0.01; ***: p,0.001. Data are combined from two independent experiments. (D) Each bar
represents absolute numbers of infiltrating Thy1.1
+CD4
+ T cells from STD or VAD recipients. Bars indicate mean values. N=4–5/group. **: p,0.01; ***:
p,0.001. Data are combined from two independent experiments.
doi:10.1371/journal.pone.0038252.g004
Figure 5. Vitamin A deficiency of recipient mice leads to increased Th1 cells and decreased FoxP3
+ Treg cells during GvHD. STD or
VAD recipient mice were analyzed for CD4
+ T cell polarization status in SPL, mLN, liver and small intestine (SI) at day 21 after transplantation. (A) Each
bar represents the percentage of FoxP3
+ CD4
+ T cells of CD4
+ T cells isolated from the indicated organ. (B) Each bar represents the percentage of IFN-
c
+ CD4
+ T cells of CD4
+ T cells isolated from the indicated organ.
doi:10.1371/journal.pone.0038252.g005
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increased CD8
+ T cell numbers in the livers of VAD recipients.
CCL2 is known to be expressed in the liver during GvHD [28]
and attracts CCR2
+CD8
+ T cells to the liver as shown previously
by others [29]. Therefore, we speculate that such inflammatory
chemokines might also contribute to the disease outcome of
GvHD under VAD conditions. Considering that the liver is the
largest vitamin A storage of the organism [30], we can not exclude
that factors other than increased homing of alloreactive T cells to
the liver might also contribute to the observed liver damage in
VAD recipients. In addition to its role in the immune system,
vitamin A deficiency has been shown to affect several functions of
vertebrates including reproduction, epithelial cell and bone
marrow differentiation and vision.
In conclusion, our study shows that induction of gut-homing
potential of allogeneic donor T cells relies on the presence of
vitamin A in the host organism. We also show that lack of this
nutrient has multiple secondary effects that trigger acute
inflammation with severe hepatic damage in this model of acute
GvHD.
Materials and Methods
Ethics Statement
All animal experiments were done in accordance with
institutional and governmental directives and were approved by
the institutional review board and the ‘‘Niedersa ¨chsisches Land-
esamt fu ¨r Verbraucherschutz und Lebensmittelsicherheit’’ (proto-
col #07/1383).
Mice
C57BL/6 (H-2K
b) Thy1.2
+, C57BL/6 Thy1.1
+ and BALB/c
(H-2K
d) mice were bred at the central animal facility of Hannover
Medical School under specific pathogen-free conditions or
purchased from Charles River Laboratories (Sulzfeld, Germany).
Vitamin A deficient BALB/c (H-2K
d) mice were prepared by
feeding them a vitamin A depleted diet from gestational day 14
[8]. Control animals received standard (STD) diet. Litters were
weaned at four weeks of age and maintained on the same diet at
least upon completion of experiments.
Antibodies and Flow Cytometric Analysis (FACS)
FACS data were acquired on LSRII (BD-Biosciences, San Jose,
CA) and analyzed using FlowJo software (Treestar, Ashland, OR).
The rat anti-mouse CCR9 (clone 7E7-1-1) was produced with rat
hybridoma cell lines [31]. The anti-mouse integrin-b7-PE (clone
LPAM-1), anti-Thy1.1-PE, CD4-PerCP, CD8-APC-Cy7 and
CD62L-FITC were purchased from BD Biosciences (San Jose,
CA). Biotinylated antibodies were recognized by strepatvidin
coupled to Alexa Fluor 405 or PE (both Invitrogen, Carlsbad, CA).
Rat and mouse sera were purchased from AbD Serotec (Oxford,
U.K.) and Invitrogen (Carlsbad, CA), respectively. For measure-
ments of intracellular cytokines, T cells were stimulated with
50 ng/mL Phorbol-12-myristate-13-acetate (PMA, Calbiochem,
Darmstadt, Germany), 2 mg/mL ionomycin (Invitrogen, Camar-
illo, CA) for 1 h, followed by further 3 h incubation in the
presence of 1 mg/mL brefeldin A (Sigma-Aldrich, St. Louis, MI).
Cells were fixed using a Fix/Perm buffer set (eBioscience, San
Diego, CA) as described in the suppliers’ manual. For intracellular
stainings, we used anti-FoxP3-APC (clone FJK-16s, eBiosciences,
San Diego, CA), anti-IL-17A-PE (clone TC11-18H10, BD-
Biosciences, San Jose, CA), IL-4-APC (clone 11B11, BD-Biosci-
ences, San Jose, CA) and anti-IFN-c-PE (XMG1.2, BioLegend or
eBiosciences, both San Diego, CA).
Analysis of T Cell Proliferation in vivo
Single-cell suspensions were prepared from red blood cell
(RBC)-lysed splenocytes by treatment with hypotonic NH4Cl, and
subsequently stained with 5 mM carboxyfluorescin diacetate
succinimidyl ester (CFSE; Molecular Probes, Eugen, OR) for 15
minutes at 37uC. 2610
7 cells were transplanted into lethally
irradiated BALB/c mice. Recipient mice were sacrificed after 72
hours and SLOs were harvested and analyzed by FACS.
Competitive Homing Experiments
Single-cell suspensions were prepared from mLNs of BALB/c
mice fed with STD or VAD food at day 3 after HSCT. After
RBC-lysis, cells were labeled with 10 mM 5-(and-6-)-TAMRA SE
or 5 mM CFSE (Invitrogen, Carlsbad, CA) for 15 min at 37uC.
C57BL/6 recipient mice (6–8 weeks old) received 5610
6 labeled T
cells in a ratio of 1:1, VAD and STD by intravenous injection into
the lateral tail vein. Sixteen hours after transfer C57BL/6 recipient
mice were sacrificed and lymphocytes were harvested for
assessment of organ infiltration.
Bone Marrow Transplantation
Lymphocytes were prepared from RBC-lysed splenocytes. The
samples were enriched for T cells using magnetic microbeads
(MACS, Pan-T cell isolation kit, Miltenyi Biotec, Auburn, CA).
The bone marrow cells were harvested from femur and tibia and
after RBC-lysis, T cells were stained with anti-TCRb biotin (clone
H57-597, BD Biosciences, San Jose, CA) and then depleted by
MACS with strepatvidin-magnetic beads (Miltenyi Biotec, Au-
burn, CA). The C57BL/6 (H-2
b) into BALB/c (H-2
d) acute
GvHD models were performed as described elsewhere [26,32]. In
brief, BALB/c recipients were lethally irradiated with 800cGy or
from a
137Cs c-Source. Donor cells were injected via tail vein at
the same day. All recipient mice received 5610
6 T cell MACS-
depleted (C57BL/6 or BALB/c) bone marrow cells and MACS-
sorted 1610
6 C57BL/6 T cells. After HSCT, mice were kept on
antibiotic drinking water (Cotrimoxazol, Ratiopharm, Ulm,
Germany) for the first three weeks. Survival, weight loss and
clinical signs of GvHD of recipient mice were monitored daily.
Mice receiving vitamin A depleted diet or control diet had
equivalent body weights at time of transplantation.
Assessment of GvHD Target Organ Infiltration and
Histology
Recipient mice were sacrificed at different time points after
HSCT and organs (spleen, liver, pLN, mLN, small intestine) were
Figure 6. Vitamin A deficiency led to increased hepatic inflammation. (A) Serum cytokine levels were analyzed using the Cytometric Bead
Array, Mouse Inflammation Kit (BD Biosciences). N=5–6/group. **: p,0.01; ***: p,0.001. Data are combined from two independent experiments. (B)
Expression analyses of cytokine levels of GvHD target organs using RT-PCR (N=6/group) Data are combined from two independent experiments (C)
Macroscopic comparison of spleen sizes of VAD and STD recipient mice. N=3/group. One of two representative experiments is shown. (D) Liver
enzymes in the course of GvHD in VAD and STD recipients. N=5–6/group. **: p,0.01; ***: p,0.001. Data are combined from two independent
experiments. (E, F) Representative sections from formalin fixed, paraffin embedded livers and small intestines harvested at 21 days post
transplantation. The 4–6 mm slides were stained with hematoxylin and eosin.
doi:10.1371/journal.pone.0038252.g006
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Single-cell suspensions of lymph nodes and spleen were obtained
by mincing the tissue through a nylon mesh. For isolation of LPL
and IEL, gut content and PPs were removed before intestines were
opened longitudinally. Intestines were washed twice in cold PBS
and once in cold PBS/5%FCS/ 5mM EDTA, and incubated
twice in RPMI1640 medium supplemented with 5%FCS and
5 mM EDTA at 37uC. Supernatants were pooled, filtered through
a nylon mesh, pelleted and resuspended (IEL fraction) [33]. The
remaining tissue was incubated twice at 37uC for 45 minutes in
RPMI1640 with 10% FCS, 0.24 mg/ml collagenase A (Roche,
Grenzach-Wyhlen, Germany) and 40 U/ml DNAse I (Roche,
Grenzach-Wyhlen, Germany). Again, supernatants were pooled,
filtered through a mesh, pelleted and resuspended (LPL fraction)
[21]. Liver lymphocytes were obtained after perfusion of the livers.
Then organs were cut into small pieces, then incubated in RPMI
1640 medium supplemented with 10% FCS, 25 mM HEPES,
0.25 mg/ml collagenase IV, and 12.5 mg/ml DNase I (Sigma-
Aldrich) for 45 min at 37uC. After incubation, enzymatic activity
was terminated by addition of EDTA to a final concentration of
20 mM. The medium was then filtered through a nylon mesh
[34]. Lymphocytes were recovered from intestinal (IEL and LPL)
and liver samples by density gradient centrifugation on Percoll
(Amersham Biosciences). Pooled lymphocytes from the IEL and
LPL fraction represent the total lymphocytes of SI in our
experiments. Samples from spleen, and liver were subjected to
RBC lysis.
Cytokine Bead Array and Liver Function Tests
Peripheral blood was obtained at different time points from
treated or untreated mice. Serum was separated, and concentra-
tions of AST and ALT were measured by an automated method
using an Olympus AU 400 analyzer (Beckman Coulter, Inc.,
Krefeld, Germany). Serum levels of the pro-inflammatory
cytokines IL-6, CCL2, TNFa and IFN-c were quantified by
bead-based flow cytometry assay (‘‘mouse inflammatory cytokine
cytometric bead array kit’’, Becton Dickinson, Franklin Lakes,
New Jersey, USA) according to the manufacturer’s protocol.
Determination of RNA Expression Levels with RT-PCR of
Liver and Intestine
Cellular RNA was extracted from snap frozen recipients ` liver or
intestinal samples using TRIZOL (Invitrogen, Carlsbad, CA)
according to the manufacturer’s protocol and first strand cDNA
was synthesized from 1 mg DNase treated total RNA. Real-time
PCR reactions were carried out on a StepOne Plus real-time PCR
system (Applied Biosystems, Foster City, CA, USA) by using the
Mcpt1, IL6, IFNg, Tnf TaqMan gene expression assays (Assay IDs:
Mcpt1: Mm00656886_g1; IL6: Mm00446190_m1; Ifng:
Mm01168134_m1; Tnf: Mm00443260_g1). GAPDH was used
as control (TaqMan Rodent GAPDH Control Reagents, Applied
Biosystems, Foster City, CA, USA).
Statistical Analysis
Statistical analysis was performed with Prism 4 (Graph-Pad
Software, Inc.). Significant values were determined using the
unpaired two-tailed t test. Statistical differences for the mean
values are as follows: *, P#0.05; **, P#0.01; and ***, P#0.001.
To analyze survival, Kaplan-Meier estimation and log-rank test
was used.
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